Heparanase has been implicated in various experimental and human glomerular diseases associated with proteinuria, including diabetes and membranous nephropathy (Shafat et al., 2011; Gil et al., 2012; Szymczak et al., 2017). This evidence concerns the gene HPSE and membranous glomerulonephritis.